List of Excipients in API dabigatran etexilate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dabigatran etexilate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | PRADAXA | dabigatran etexilate | 0597-0425 | ACACIA | |
| Boehringer Ingelheim Pharmaceuticals Inc | PRADAXA | dabigatran etexilate | 0597-0425 | DIMETHICONE | |
| Boehringer Ingelheim Pharmaceuticals Inc | PRADAXA | dabigatran etexilate | 0597-0425 | HYDROXYPROPYL CELLULOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dabigatran etexilate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 | AMMONIA |
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 | CELLULOSE, MICROCRYSTALLINE |
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 | CROSPOVIDONE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for dabigatran etexilate
Excipient focus: ACACIA
dabigatran etexilate drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| DrReddys Laboratories Inc | dabigatran etexilate | 43598-642 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
dabigatran etexilate drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
dabigatran etexilate drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| AvKARE | dabigatran etexilate | 42291-034 |
| DrReddys Laboratories Inc | dabigatran etexilate | 43598-642 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
dabigatran etexilate drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | dabigatran etexilate | 43598-642 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
dabigatran etexilate drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARRAGEENAN
dabigatran etexilate drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | dabigatran etexilate | 43598-642 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Aurobindo Pharma Limited | dabigatran etexilate | 59651-973 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
dabigatran etexilate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID
dabigatran etexilate drug variants containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
dabigatran etexilate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
dabigatran etexilate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | dabigatran etexilate | 42291-034 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7530 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7531 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
dabigatran etexilate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: CURRY RED
dabigatran etexilate drug variants containing CURRY RED
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing CURRY RED
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEHYDRATED ALCOHOL
dabigatran etexilate drug variants containing DEHYDRATED ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | dabigatran etexilate | 43598-642 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing DEHYDRATED ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
dabigatran etexilate drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| DrReddys Laboratories Inc | dabigatran etexilate | 43598-642 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
dabigatran etexilate drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dabigatran etexilate | 59651-973 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
dabigatran etexilate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
dabigatran etexilate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
dabigatran etexilate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
dabigatran etexilate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Aurobindo Pharma Limited | dabigatran etexilate | 59651-973 |
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
dabigatran etexilate drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
dabigatran etexilate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
dabigatran etexilate drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| >Company | >Ingredient | >NDC |
Excipient focus: FUMARIC ACID
dabigatran etexilate drug variants containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
dabigatran etexilate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dabigatran etexilate | 59651-973 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL METHYLCELLULOSE
dabigatran etexilate drug variants containing HYDROXYPROPYL METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYDROXYPROPYL METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
dabigatran etexilate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | dabigatran etexilate | 42291-034 |
| DrReddys Laboratories Inc | dabigatran etexilate | 43598-642 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7530 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
dabigatran etexilate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| AvKARE | dabigatran etexilate | 42291-034 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| DrReddys Laboratories Inc | dabigatran etexilate | 43598-642 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE PHTHALATE
dabigatran etexilate drug variants containing HYPROMELLOSE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYPROMELLOSE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
dabigatran etexilate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | dabigatran etexilate | 43598-642 |
| XLCare Pharmaceuticals Inc | dabigatran etexilate | 72865-272 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
dabigatran etexilate drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
dabigatran etexilate drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dabigatran etexilate | 59651-973 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
dabigatran etexilate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| AvKARE | dabigatran etexilate | 42291-034 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7530 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
dabigatran etexilate drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
dabigatran etexilate drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
dabigatran etexilate drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEG-12
dabigatran etexilate drug variants containing PEG-12
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing PEG-12
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
dabigatran etexilate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 600
dabigatran etexilate drug variants containing POLYETHYLENE GLYCOL 600
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Ascend Laboratories LLC | dabigatran etexilate | 67877-475 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POLYETHYLENE GLYCOL 600
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
dabigatran etexilate drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
dabigatran etexilate drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | dabigatran etexilate | 43598-642 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Aurobindo Pharma Limited | dabigatran etexilate | 59651-973 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
dabigatran etexilate drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
dabigatran etexilate drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
dabigatran etexilate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Alembic Pharmaceuticals Limited | dabigatran etexilate | 46708-634 |
| Alembic Pharmaceuticals Inc | dabigatran etexilate | 62332-634 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
dabigatran etexilate drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
dabigatran etexilate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Aurobindo Pharma Limited | dabigatran etexilate | 59651-973 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
dabigatran etexilate drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
dabigatran etexilate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
Excipient focus: SOYBEAN LECITHIN
dabigatran etexilate drug variants containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dabigatran etexilate | 59651-973 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
dabigatran etexilate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| XLCare Pharmaceuticals Inc | dabigatran etexilate | 72865-272 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
dabigatran etexilate drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| American Health Packaging | dabigatran etexilate | 60687-744 |
| XLCare Pharmaceuticals Inc | dabigatran etexilate | 72865-272 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUNSET YELLOW
dabigatran etexilate drug variants containing SUNSET YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dabigatran etexilate | 50090-7656 |
| A-S Medication Solutions | dabigatran etexilate | 50090-7657 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing SUNSET YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
dabigatran etexilate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
dabigatran etexilate drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Apotex Corp | dabigatran etexilate | 60505-4347 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
dabigatran etexilate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| Camber Pharmaceuticals Inc | dabigatran etexilate | 31722-621 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
dabigatran etexilate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | dabigatran etexilate mesylate | 21695-899 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
dabigatran etexilate drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dabigatran etexilate | 59651-973 |
| >Company | >Ingredient | >NDC |
dabigatran etexilate drug variants not containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dabigatran etexilate | 0378-0265 |
| Boehringer Ingelheim Pharmaceuticals Inc | dabigatran etexilate | 0597-0425 |
| Major Pharmaceuticals | dabigatran etexilate | 0904-7253 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
